Blog

Jemma Arakelyan: Joining Panel with Nobel Laureate Aaron Ciechanover at 2025 Lindau Meeting is Surreal

Jemma Arakelyan/LinkedIn

Jun 15, 2025, 12:11

Jemma Arakelyan: Joining Panel with Nobel Laureate Aaron Ciechanover at 2025 Lindau Meeting is Surreal

Jemma Arakelyan, Medical Oncologist and CEO of Institute of Cancer and Crisis, shared a post on LinkedIn:

“Attending the Lindau Meeting was already a dream come true, but being selected to be on a panel with Nobel Laureate Professor Aaron Ciechanover, alongside Dr. Hagen Schroeter and Adam Smith, is surreal!

A huge thank you to Dr. Abigail Stevenson and Dr. Hagen Schroeter for believing in me and supporting my journey.

Grateful for this opportunity to represent the next generation of scientists!

Professor Aaron Ciechanover is an acclaimed Israeli biochemist best known for his pioneering research in the field of cellular regulation and protein degradation. He was awarded the Nobel Prize in Chemistry in 2004, along with Avram Hershko and Irwin Rose, for their discovery of the ubiquitin-proteasome pathway, a fundamental mechanism that regulates protein turnover in cells.”

Aaron Ciechanover

More posts featuring Jemma Arakelyan on OncoDaily.

2025 Lindau Meeting Aaron Ciechanover Abigail Stevenson Adam Smith Avram Hershko cancer Hagen Schroeter Irwin Rose Jemma Arakelyan Nobel Laureate Aaron Ciechanover Nobel prize OncoDaily Oncology

Smoking and Bladder Cancer: What You Need to Know to Protect Yourself

Cervical Cancer Screening: Who Needs a Pap Smear or HPV Test and When?

Clinical Trials in Cancer Care: What They Are, How to Join, and What to Expect

Linda Evangelista and Breast Cancer: How She Went Against, How She Survived, and More

Agenus Enters New Era With $141M Zydus Deal Signaling Strategic Transformation in Immuno-Oncology